Latest filing published 07 Nov 2018 for Oasmia Pharmaceutical AB, €640k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Julian Aleksov: trading record in brief
All filings by Julian Aleksov on record concern Oasmia Pharmaceutical AB. The record holds 4 filings, for trades running from 6 September 2018 to 5 November 2018.
In open-market terms, that means 2 purchases worth €37k on one side and 1 sale worth €43k on the other. On balance, insiders were net sellers of €5,649. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The newest entry dates from 7 November 2018: a transaction of €640k, in Oasmia Pharmaceutical AB. The most recent open-market purchase was published on 28 September 2018, 2,964 days ago. Filings reach the Finansinspektionen feed a median of 2 days after the trade. For comparison, MAR article 19 gives managers three business days to notify a trade. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Julian Aleksov
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 857,142 shares@ SEK 7.7089.0% of flowKonvertibelISIN SE0011644764FI:csv-0a03ade7ad40be9daf0f
- 36,751 shares@ SEK 12.005.9% of flowAktieISIN SE0000722365FI:csv-b841382c6a6e7e705eb7
- 9,500 shares@ SEK 14.401.8% of flowAktieISIN SE0000722365FI:csv-245fbdcce76ca54c711fCanonical exit: 26 Dec 2018 (T+90)
- 36,751 shares@ SEK 6.803.3% of flowISIN SE0000722365FI:csv-5ba49d876cfd90391da4Canonical exit: 5 Dec 2018 (T+90)
4 of 4 declarations